Shay Capital’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Shay Capital’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23,456	Closed	-$148K	–	547
2022 Q4	$148K	Buy	+23,456	New	+$130K	0.05%	204

Shay Capital's FSTX Position: Q1 2023 in Review

Shay Capital sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 23,456 shares — an estimated $148K sold.

Shay Capital first reported a position in FSTX in Q4 2022 and held it in 1 quarter. The position peaked at $148K in Q4 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

Shay Capital reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Shay Capital sold 23,456 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $148K.
Shay Capital first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Shay Capital's F-star Therapeutics, Inc. Common Stock position peaked at $148K in Q4 2022.
0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Shay Capital's 13F filing for Q1 2023, filed 15 May 2023.